Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial

Arthritis and Rheumatism
Vidya SankarStanley R Pillemer

Abstract

To assess the safety and potential efficacy of etanercept in the treatment of Sjögren's syndrome (SS). This pilot study was a 12-week randomized, double-blind, placebo-controlled trial of etanercept, with 14 subjects in each group. Patients received 25 mg of etanercept or placebo (vehicle) by twice-weekly subcutaneous injection. Patients met the American-European Consensus Group criteria for SS. The primary outcome required at least 20% improvement from baseline values for at least 2 of the following 3 domains: subjective or objective measures of dry mouth, subjective or objective measures of dry eyes, and IgG level or erythrocyte sedimentation rate (ESR). Of the 14 patients taking etanercept, 11 had primary SS and 3 had SS secondary to rheumatoid arthritis. Baseline measures did not differ between the 2 groups. Three etanercept-treated patients and 1 placebo-treated patient did not complete the trial. Five etanercept-treated patients and 3 placebo-treated patients showed improvement from baseline in the primary outcome variable at 12 weeks, but the difference was not statistically significant. There were no significant differences between the groups for changes in subjective measures of oral or ocular symptoms (by visual analo...Continue Reading

References

May 1, 1986·Arthritis and Rheumatism·R I FoxF V Howell
Jul 1, 1969·Archives of Ophthalmology·O P van Bijsterveld
May 1, 1994·The American Journal of Medicine·P B Beeson
Feb 1, 1993·Optometry and Vision Science : Official Publication of the American Academy of Optometry·P Cho, M Yap
Jan 1, 1996·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·P C Fox, P M Speight
Sep 30, 1999·Current Opinion in Rheumatology·R I FoxP Michelson
Jul 27, 2001·Scandinavian Journal of Rheumatology. Supplement·F B Vivino
Oct 23, 2001·Arthritis and Rheumatism·S D SteinfeldT Appelboom
Apr 12, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Roy FleischmannAndres Quiceno
May 15, 2002·Annals of the Rheumatic Diseases·C VitaliUNKNOWN European Study Group on Classification Criteria for Sjögren's Syndrome
Dec 17, 2002·Arthritis and Rheumatism·Serge D SteinfeldThierry Appelboom
Mar 5, 2003·Advances in Experimental Medicine and Biology·Robert I Fox

❮ Previous
Next ❯

Citations

Jun 2, 2006·Springer Seminars in Immunopathology·Burkhard Möller, Peter M Villiger
Sep 28, 2006·Zeitschrift für Rheumatologie·C Tomiak, T Dörner
Nov 14, 2007·Zeitschrift für Rheumatologie·E FeistA Hansen
Nov 7, 2013·Zeitschrift für Rheumatologie·I Kötter, J C Henes
Nov 10, 2007·Clinical Reviews in Allergy & Immunology·Jiska M MeijerCees G M Kallenberg
Nov 10, 2007·Clinical Reviews in Allergy & Immunology·Gikas E KatsifisSharon M Wahl
Nov 10, 2013·Archives of Oral Biology·Keiko Aota, Masayuki Azuma
Apr 26, 2005·Journal of Autoimmunity·Jacques-Eric GottenbergXavier Mariette
May 3, 2012·Nature Reviews. Rheumatology·Manuel Ramos-CasalsAthanasios G Tzioufas
Feb 12, 2010·Rheumatology·Wan-Fai Ng, Simon J Bowman
Aug 12, 2005·Current Opinion in Rheumatology·Arne HansenThomas Dörner
Nov 18, 2008·Medicine·Manuel Ramos-CasalsUNKNOWN BIOGEAS STUDY Group
Jan 16, 2007·Annals of the Rheumatic Diseases·J M van WoerkomJ W J Bijlsma
Oct 14, 2006·Annals of the Rheumatic Diseases·D E FurstM H Weisman
Nov 21, 2007·Annals of the Rheumatic Diseases·D E FurstM E Weinblatt
Jun 30, 2009·Annals of the Rheumatic Diseases·Raphaèle SerorUNKNOWN EULAR Sjögren's Task Force
Apr 23, 2010·Annals of the Rheumatic Diseases·Nienke RoescherGabor G Illei
Jan 10, 2012·International Journal of Rheumatology·Courtney L Kraus, Susan M Culican
Jun 1, 2010·Therapeutic Advances in Musculoskeletal Disease·Claudio VitaliPierluigi Cataleta
Mar 5, 2011·Arthritis Research & Therapy·Cees G M KallenbergHendrika Bootsma
Jul 13, 2011·Arthritis Research & Therapy·Cándido Díaz-LagaresUNKNOWN BIOGEAS Study Group
Mar 4, 2005·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Noriyoshi OgawaTakafumi Kawanami
Nov 26, 2009·Joint, Bone, Spine : Revue Du Rhumatisme·J-E Gottenberg
Jan 26, 2013·Expert Opinion on Pharmacotherapy·Pilar Brito-ZerónManuel Ramos-Casals
Mar 22, 2014·Expert Review of Clinical Immunology·Alia FazaaJacques-Eric Gottenberg
Apr 14, 2010·Expert Opinion on Emerging Drugs·Gabriel J TobónPierre Youinou
Aug 9, 2011·Expert Opinion on Biological Therapy·Petra M MeinersHendrika Bootsma
Feb 10, 2006·Scandinavian Journal of Rheumatology·R ManthorpeA Larsson
Apr 5, 2011·Expert Opinion on Biological Therapy·Wan-Fai Ng, Simon J Bowman
Sep 23, 2010·Scandinavian Journal of Rheumatology·J C F van LuijnH G M Leufkens
Jan 26, 2016·Expert Opinion on Drug Safety·Jolien F van NimwegenArjan Vissink
Sep 17, 2005·Pharmacotherapy·David J Rychly, Joseph T DiPiro
Mar 3, 2007·Annals of the New York Academy of Sciences·Philip C Fox
Feb 20, 2008·Oral Diseases·Y ShirotaN P Nikolov
Sep 26, 2007·Annals of the New York Academy of Sciences·Roland JonssonJohan G Brun
Sep 19, 2006·Best Practice & Research. Clinical Rheumatology·P J Venables
Aug 2, 2014·Clinical Reviews in Allergy & Immunology·Valéria ValimRubens Belfort
Sep 12, 2015·Revista brasileira de reumatologia·Valéria ValimWanderley Marques Bernardo
Jul 29, 2015·Seminars in Arthritis and Rheumatism·Coziana CiurtinDavid A Isenberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.